en · de · es · fr · pt
tb-500-notes.peptides9002.com › Data › Handling, Storage, And Analytical Verification — Quick Reference

Handling, Storage, And Analytical Verification — Quick Reference

By Editorial Desk · published 2026-06-03 · last reviewed 2026-07-15 · Data

The short version of wound model fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-07-15. Anything still debated is marked as such rather than presented as settled.

Handling, Storage, and Analytical Verification

The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.

Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.

Identity and Reported Background

Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.

TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.

Tb-500 at a glance

PropertyValueNotes
AppearanceWhite to off-white powderLyophilized cake or fluffy solid
Water solubilityHighDissolves in water and neutral buffers
Dry storage-20 °C or belowDry, dark, desiccated
Reconstituted storageFrozen, single thawRepeated freeze-thaw promotes loss
Purity methodReverse-phase HPLCPeak area read at 214 or 220 nm

TB-500 Identity and Molecular Background

TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.

Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.

Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.

Related pages on this site

Research Framing and Evidence Base

Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.

Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.

Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.

Notes from published material

Glycogen storage disease type II (GSD-II), also called Pompe disease, and formerly known as GSD-IIa or Limb–girdle muscular dystrophy 2V, is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body. It is caused by an accumulation of glycogen in the lysosome due to a deficiency of the lysosomal acid alpha-glucosidase enzyme (GAA). The inability to break down glycogen within the lysosomes of cells leads to progressive muscle weakness throughout the body and affects various body tissues, particularly in the heart, skeletal muscles, liver, and the nervous system. GSD-II and Danon disease are the only glycogen storage diseases characterised by a defect in lysosomal metabolism. It was first identified in 1932 by Dutch pathologist Joannes Cassianus Pompe, making it the first glycogen storage disease to be discovered.

=== Films === Kung-Fu Master (1988) – directed by Agnès Varda Trop (peu) d'amour (1998) – directed by Jacques Doillon Mauvaises fréquentations (1999) – directed by Jean-Pierre Améris Mamirolle (2000) – directed by Brigitte Coscas Carrément à l'ouest (2001) – directed by Jacques Doillon Embrassez qui vous voudrez (2002) – directed by Michel Blanc Blanche (2002) – directed by Bernie Bonvoisin Saint Ange (2004) – directed by Pascal Laugier La Vida perra de Juanita Narboni (2005) – of Farida Benlyazid Sisters (2006) – directed by Douglas Buck Go Go Tales (2007) – directed by Abel Ferrara Boxes (2007) – directed by Jane Birkin and starring Birkin, Geraldine Chaplin, Michel Piccoli and Natacha Régnier Bazar (2009) – directed by Patricia Plattner and starring Bernadette Lafont Gigola (2010) – directed by Laure Charpentier Naked in London (2011) – directed by Mark Tierney Polisse (2011) – directed by Maïwenn Un enfant de toi (2012) – directed by Jacques Doillon Quasi a Casa (2024) - directed by Carolina Pavone

=== Antioxidant defenses === During their transit through the epididymis, the spermatozoa undergo a series of transformations in preparation for their ultimate task of fertilizing the oocyte. To protect the spermatozoa during their transit through the epididymis, the epididymal epithelium produces a variety of antioxidant proteins that help protect the spermatozoa from oxidative damage. The antioxidant proteins produced include catalase, glutathione peroxidases, glutathione-S-transferases, peroxiredoxins, superoxide dismutases, thioredoxin reductase and thioredoxins. Deficiencies in the availability of these antioxidant proteins reduces sperm quality by affecting a variety of the proteins necessary for the motility needed to fertilize oocytes. Reduced antioxidant activity also causes increased oxidative damage to the sperm DNA.

Legumin is a conjugated protein with six subunits. The individual subunits have a hydrophilic α chain that is initially linked to the smaller hydrophobic β chain with a peptide bond. Both the α and β chains are encoded by the same gene. Each of the six subunits has a mass of ~50-60 kDa. During translation of the α and β chains, the polypeptide is inserted into the endoplasmic reticulum (ER) where the signal peptide that initiated the cell to translocate the chains is cleaved. A disulfide bridge is formed between the α and β chains to form prolegumin, a protein precursor. Three of these subunits come together to form a trimer in the ER. The trimer of prolegumins can be transported to the vacuole for further post-translational modification. In the vacuole, the peptide bond formed between the α and β chains is cleaved now that the disulfide bridge holds the two chains together. The cleavage of the α and β chains within the trimers signals protein maturation where two trimers to come together and form the final hexameric legumin protein.

Sources: en.wikipedia.org

Background from the literature

== Corruption == Corruption Perceptions Index 2019: Thailand ranked 101 of 180 nations (1=cleanest; 180=most corrupt). Other ASEAN nations ranked: Singapore, 4; Brunei, 35; Malaysia, 51; Indonesia, 85; Vietnam, 96; Philippines, 113; Myanmar, 130; Laos, 130 (tie); and Cambodia, 162. Corruption Perceptions Index 2018: Thailand ranked 99 of 180 nations (1=clean; 180=most corrupt). Other ASEAN nations ranked: Singapore, 3; Brunei, 31; Malaysia, 61; Indonesia, 89; Philippines, 99 (tie); Vietnam, 117; Myanmar, 132; Laos, 132 (tie); and Cambodia, 161. Corruption Perceptions Index 2017: Thailand ranked 96 of 180 nations (1=clean; 180=most corrupt). Other ASEAN nations ranked: Singapore, 6; Brunei, 32; Malaysia, 62; Indonesia, 96 (tie); Vietnam, 107; Philippines, 111; Myanmar, 130; Laos, 135; and Cambodia, 161. Corruption Perceptions Index 2016: Thailand ranked 101 of 176 nations (1=clean; 176=most corrupt). Other ASEAN nations ranked: Singapore, 7; Brunei, 41; Malaysia, 56; Indonesia, 90; Philippines, 101; Vietnam, 113; Laos, 123; Myanmar, 136; and Cambodia, 156. Corruption Perceptions Index 2015: Thailand ranked 76 of 167 nations (1=clean; 167=most corrupt) on this annual survey. Other ASEAN nations were ranked: Singapore, 8; Malaysia, 54; Indonesia, 88; Philippines, 95; Vietnam, 112; Laos, 139; Myanmar, 147; and Cambodia, 150. Corruption Perceptions Index 2014: Transparency International's CPI 2014 ranked Thailand 85 of 174 countries (1=clean; 174=most corrupt).

== Procedure == One or more subjects (usually, pilots or crew members, though anyone interested in the effects of high altitude can usually arrange a visit) are placed in the chamber. Before "ascending" to the desired altitude, subjects breathe oxygen from oxygen masks to purge nitrogen from their bloodstream so decompression sickness (DCS) does not occur. With masks in place, the atmospheric pressure inside the chamber is then reduced to simulate altitudes of up to tens of thousands of feet. The subjects then remove their oxygen masks and experience the symptoms of hypoxia. An inside safety observer, breathing oxygen by mask, should always be present to place a subject's mask back on in the event a subject passes out unconscious. Outside observers monitor the subjects' condition via closed circuit television and viewing ports. While the masks are off, subjects may be asked to do trivial tasks, such as arithmetic and signing their own names. When such tasks start taking excessive lengths of time to be done or are done poorly, it is usually a sign that the "time of useful consciousness" has been exceeded and that the masks should be replaced. Subjects may also ensure that they are able to do tasks such as clear their nose and sinuses easily, as pain from such problems can be a major distraction in an emergency such as rapid decompression.

DASH7's potential to automate check-ins and check-outs provides essential infrastructure to location-based advertising and promotions Automotive — DASH7 is increasingly seen as the next-generation tire-pressure monitoring system (TPMS), given its operation at the same frequency (433 MHz) as nearly all proprietary TPMS today. DASH7-based TPMS will provide end users with more accurate tire pressure readings, resulting in greater fuel economy, reduced tire wear, and greater safety. DASH7 products are also being designed and used for other automotive applications like supply chain visibility. Logistics — DASH7 is being used today for tracking the whereabouts of shipping containers, pallets, roll cages, trucks, rail cars, maritime vessels, and other supply chain assets, providing businesses with unprecedented visibility into their everyday operations. Also cold chain management (vaccines, fresh produce, cut flowers, etc.), whereby DASH7 is used for monitoring the in-transit temperature and other environmental factors that can adversely affect the integrity of sensitive products.

Sources: en.wikipedia.org

Reference notes

=== Design of globular proteins === Globular proteins are proteins that contain a hydrophobic core and a hydrophilic surface. Globular proteins often assume a stable structure, unlike fibrous proteins, which have multiple conformations. The three-dimensional structure of globular proteins is typically easier to determine through X-ray crystallography and nuclear magnetic resonance than both fibrous proteins and membrane proteins, which makes globular proteins more attractive for protein design than the other types of proteins. Most successful protein designs have involved globular proteins. Both RSD-1, and Top7 were de novo designs of globular proteins. Five more protein structures were designed, synthesized, and verified in 2012 by the Baker group. These new proteins serve no biotic function, but the structures are intended to act as building-blocks that can be expanded to incorporate functional active sites. The structures were found computationally by using new heuristics based on analyzing the connecting loops between parts of the sequence that specify secondary structures.

=== Repair === If hyaline cartilage is torn all the way down to the bone, the blood supply from inside the bone is sometimes enough to start some healing inside the lesion. In cases like this, the body will form a scar in the area using a special type of cartilage called fibrocartilage. Fibrocartilage is a tough, dense, and fibrous material that helps fill in the torn part of the cartilage; however, it is not an ideal replacement for the smooth, glassy articular cartilage that normally covers the surface of joints.

There is, however, little research on whether female condoms are as effective as male condoms at preventing STIs, and they are slightly less effective than male condoms at preventing pregnancy, which may be because the female condom fits less tightly than the male condom or because it can slip into the vagina and spill semen. The vaginal lymph nodes often trap cancerous cells that originate in the vagina. These nodes can be assessed for the presence of disease. Selective surgical removal (rather than total and more invasive removal) of vaginal lymph nodes reduces the risk of complications that can accompany more radical surgeries. These selective nodes act as sentinel lymph nodes. Instead of surgery, the lymph nodes of concern are sometimes treated with radiation therapy administered to the patient's pelvic, inguinal lymph nodes, or both. Vaginal cancer and vulvar cancer are very rare, and primarily affect older women. Cervical cancer (which is relatively common) increases the risk of vaginal cancer, which is why there is a significant chance for vaginal cancer to occur at the same time as, or after, cervical cancer. It may be that their causes are the same. Cervical cancer may be prevented by pap smear screening and HPV vaccines, but HPV vaccines only cover HPV types 16 and 18, the cause of 70% of cervical cancers. Some symptoms of cervical and vaginal cancer are dyspareunia, and abnormal vaginal bleeding or vaginal discharge, especially after sexual intercourse or menopause. However, most cervical cancers are asymptomatic (present no symptoms).

For a given total heat output, reducing waste volume increases heat density; the space required in a repository also depends on the host rock and its temperature limits. Radioactivity is not the same as the dose potentially received from a waste repository. A 2023 DOE assessment noted that waste radiotoxicity is strongly linked to actinide content, while mobile, long-lived fission and activation products can be important contributors to repository dose. Under typical repository conditions, actinides move more slowly than these products. In principle, breeder fuel cycles can recycle and consume all actinides, leaving only fission products. The table illustrates the gap between medium-lived and long-lived fission products. A 2015 measurement put the half-life of samarium-151, one of the medium-lived fission products, at 94.6±0.6 years. As a result of this physical oddity, after several hundred years in storage, the activity of the radioactive waste from an FBR would quickly drop to the low level of the long-lived fission products. However, to obtain this benefit requires the highly efficient separation of transuranics from spent fuel. If the fuel reprocessing methods used leave a large fraction of the transuranics in the final waste stream, this advantage would be greatly reduced. The FBR's fast neutrons can fission actinide nuclei with even numbers of both protons and neutrons. Such nuclei usually lack the low-speed "thermal neutron" resonances of fissile fuels used in LWRs. The thorium fuel cycle inherently produces lower levels of heavy actinides.

Sources: en.wikipedia.org

Frequently asked questions

Can the powder be stored at room temperature?

Short transit at ambient temperature is generally tolerated, but long-term storage at room temperature is not recommended. Heat, moisture, and light all accelerate degradation. Cold, dry, dark storage is the conventional choice.

How is purity normally reported?

Suppliers typically quote a percentage derived from reverse-phase HPLC peak area. That figure reflects the relative amount of the main peak and does not by itself confirm identity or exclude related impurities. Mass spectrometry is commonly paired with it for confirmation.

Why does the counter-ion matter?

Peptides purified by reverse-phase chromatography often carry trifluoroacetate as a counter-ion, which adds mass and can affect solubility and apparent behavior in assays. Acetate and hydrochloride forms are also offered. Knowing which form is present matters when calculating how much peptide a given weight contains.

What is TB-500 made of?

Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.

Network